There are 2789 resources available
LBA62 - Efficacy and safety of tanezumab in subjects with cancer pain predominantly due to bone metastasis receiving background opioid therapy
Presenter: Marie Fallon
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
LBA64 - Olanzapine, an alternative to dexamethasone for preventing nausea and vomiting induced by cisplatin-based doublet highly emetogenic chemotherapy: A non-inferiority, prospective, multi-centered, randomized, controlled, phase III clinical trial
Presenter: Zhigang Liu
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1526MO - GEMMK: A phase I study of gemcitabine (gem) and pembrolizumab (pem) in patients (pts) with leiomyosarcoma (LMS) and undifferentiated pleomorphic sarcoma UPS)
Presenter: Alannah Smrke
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1527MO - Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
Presenter: Nicholas Klemen
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1759MO - Associations between sarcopenia and gut microbiota in patients (pts) with metastatic renal cell carcinoma (mRCC) and breast cancer (BC)
Presenter: Zeynep Zengin
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
61MO - Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199
Presenter: Julie Graff
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
864MO - Role of geriatric assessment in tailoring treatment of locally advanced head and neck cancer: The ELDERLY study
Presenter: Paolo Bossi
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
865MO - RMAC study: A randomized study evaluating the efficacy of metronomic adjuvant chemotherapy in patients with recurrent head and neck cancers post salvage surgery, not eligible for re-irradiation
Presenter: Nandini Menon
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
1671MO - Impact of antibiotic (ATB) exposure prior to immune checkpoint inhibitor (ICI) treatment on overall survival (OS): A population-based study
Presenter: Lawson Eng
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
LBA63 - Placebo-controlled, double-blinded phase Ⅲ study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial
Presenter: Kazuhiro Shimomura
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast